[go: up one dir, main page]

AU2002250904A1 - Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine - Google Patents

Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine

Info

Publication number
AU2002250904A1
AU2002250904A1 AU2002250904A AU2002250904A AU2002250904A1 AU 2002250904 A1 AU2002250904 A1 AU 2002250904A1 AU 2002250904 A AU2002250904 A AU 2002250904A AU 2002250904 A AU2002250904 A AU 2002250904A AU 2002250904 A1 AU2002250904 A1 AU 2002250904A1
Authority
AU
Australia
Prior art keywords
mucoadhesive
veterinary
active
pharmaceutical preparation
human medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002250904A
Other versions
AU2002250904B2 (en
Inventor
Petra Brandt
Markus Krumme
Tina Rademacher
Frank Seiberts
Christian Von Falkenhausen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10107659A external-priority patent/DE10107659B4/en
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU2002250904A1 publication Critical patent/AU2002250904A1/en
Application granted granted Critical
Publication of AU2002250904B2 publication Critical patent/AU2002250904B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002250904A 2001-02-19 2002-02-08 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine Ceased AU2002250904B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10107659.2 2001-02-19
DE10107659A DE10107659B4 (en) 2001-02-19 2001-02-19 Mucoadhesive disintegratable drug preparation for drug administration in veterinary and human medicine
PCT/EP2002/001314 WO2002066016A2 (en) 2001-02-19 2002-02-08 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine

Publications (2)

Publication Number Publication Date
AU2002250904A1 true AU2002250904A1 (en) 2003-02-27
AU2002250904B2 AU2002250904B2 (en) 2006-05-04

Family

ID=7674531

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002250904A Ceased AU2002250904B2 (en) 2001-02-19 2002-02-08 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine

Country Status (18)

Country Link
US (1) US8906406B2 (en)
EP (1) EP1368004B1 (en)
JP (2) JP2004529101A (en)
KR (1) KR20030076687A (en)
CN (1) CN1599599A (en)
AR (1) AR033418A1 (en)
AT (1) ATE429213T1 (en)
AU (1) AU2002250904B2 (en)
BR (1) BR0207614A (en)
CA (1) CA2438651C (en)
DE (2) DE10107659B4 (en)
DK (1) DK1368004T3 (en)
ES (1) ES2328115T3 (en)
HK (1) HK1060055A1 (en)
MX (1) MXPA03007434A (en)
PT (1) PT1368004E (en)
WO (1) WO2002066016A2 (en)
ZA (1) ZA200306563B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (en) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
US6887493B2 (en) * 2000-10-25 2005-05-03 Adi Shefer Multi component controlled release system for oral care, food products, nutraceutical, and beverages
DE10224612A1 (en) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Active substance-containing film-like preparations with improved chemical stability, and process for their preparation
DE10251963A1 (en) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Wafer-form transmucosal dosage form, comprising solution of active agent, e.g. for combating drug abuse, in phosphatidyl choline fraction, providing both rapid and constant release via the oral cavity
DE10256774A1 (en) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Medicament for transmucosal or transdermal drug administration, containing combination of monoterpene and polyol, e.g. menthol and propanediol, as resorption improvers
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
DE102004017030A1 (en) * 2004-04-02 2005-10-20 Schering Ag Flat system for use in the oral cavity, e.g. for transmucosal drug delivery, comprises an intermediate, active agent-containing layer sealed between two covering layers of higher surface area
FI20041425A0 (en) * 2004-11-05 2004-11-05 Orion Corp Transmucosal veterinary composition
RU2007127999A (en) * 2004-12-23 2009-01-27 МакНЕЙЛ-ППС, ИНК. (US) ORAL DISINFECTING PHARMACEUTICAL COMPOSITIONS WITH SENSOR SIGNAL AGENTS
JP5507840B2 (en) * 2005-09-19 2014-05-28 ユニバーシティ・オブ・ザ・ウィットウォータースランド・ヨハネスブルグ Oral mucosa pharmaceutical dosage form
JP5214464B2 (en) * 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション Delivery medium for probiotic bacteria, in the form of glass, comprising a dry matrix of polysaccharides, saccharides and polyols and method for producing the same
JP5403585B2 (en) * 2006-01-23 2014-01-29 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム Delivery system for active agents
DE102006027795A1 (en) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Smoking cessation combination wafer
DE102006027794A1 (en) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertensive combination wafer
EP2117354B1 (en) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. A dry food product containing live probiotic
FR2935084B1 (en) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques ADDITIVE FOR ANIMAL FEED AND METHOD FOR PREPARING THE SAME
EP3266448B1 (en) 2009-03-27 2022-02-16 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
MY157343A (en) 2009-05-26 2016-05-31 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
LT2603100T (en) 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Dry storage stabilizing composition for biological materials
FR2972327B1 (en) * 2011-03-11 2017-08-11 Laboratoires Le Stum MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION
DE102014116903A1 (en) * 2014-08-18 2016-02-18 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineole-containing composition for nasal administration
DE102014119576A1 (en) 2014-12-23 2016-06-23 Ernst-Moritz-Arndt-Universität Greifswald Pharmaceutical form for administration to mucous membranes
WO2017019273A1 (en) 2015-07-29 2017-02-02 Advanced Bionutrition Corporation Stable dry probiotic compositions for special dietary uses
DE102017112527B4 (en) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Fast disintegrating foam wafers with a high basis weight
WO2019086716A1 (en) 2017-11-06 2019-05-09 Besthealth4U, Unipessoal Lda Adhesion materials and methods of manufacture
US12239893B2 (en) 2018-01-31 2025-03-04 Gary R. Krause Speed-pong game
WO2021056109A1 (en) * 2019-09-24 2021-04-01 Medisca Pharmaceutique Inc. Gel base composition for compounding into a mucoadhesive delivery system
DE102021130950A1 (en) * 2021-11-25 2023-05-25 Lts Lohmann Therapie-Systeme Ag. application help
CN116459268B (en) * 2023-03-29 2024-09-20 淄博维希尔生物技术有限公司 Solution composition containing tilmicosin and preparation method thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4329333A (en) * 1980-11-24 1982-05-11 Arthur Barr Method for the oral treatment of dogs and other animals
US4597959A (en) * 1982-04-30 1986-07-01 Arthur Barr Sustained release breath freshener, mouth and palate coolant wafer composition and method of use
US5225196A (en) * 1983-11-14 1993-07-06 Columbia Laboratories, Inc. Bioadhesive compositions and methods of treatment therewith
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
JP2702953B2 (en) * 1988-01-30 1998-01-26 オリンパス光学工業株式会社 Chemical impregnated ceramics
US4948580A (en) * 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5750136A (en) * 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5558880A (en) * 1989-12-22 1996-09-24 Janssen Pharmaceutica Inc. Pharmaceutical and other dosage forms
DE4018247A1 (en) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts MANUFACTURING METHOD FOR QUICK-DISINFITTING FILM-SHAPED PHARMACEUTICAL FORMS
US5496559A (en) * 1991-04-08 1996-03-05 Sumitomo Pharmaceuticals Company, Limited Porous solid formulations containing proteinaceous physiologically active substances
IT1250421B (en) * 1991-05-30 1995-04-07 Recordati Chem Pharm CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION WITH BIO-ADHESIVE PROPERTIES.
EP0633766B1 (en) * 1992-03-30 1998-01-07 Smithkline Beecham Corporation Moisturizer
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US6066337A (en) * 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US5516522A (en) * 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
DE4419824A1 (en) 1994-06-07 1995-12-14 Lohmann Therapie Syst Lts Volume-expandable, flat application form suitable as an active ingredient carrier, in particular for oral use
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
DE19646392A1 (en) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
DE19652257A1 (en) * 1996-12-16 1998-06-18 Lohmann Therapie Syst Lts Individually dosed, film-like dosage form that quickly disintegrates on contact with liquid and contains active ingredients and especially flavorings
IT1289160B1 (en) * 1997-01-08 1998-09-29 Jagotec Ag FULLY COATED PHARMACEUTICAL TABLET FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS WHICH PRESENT PROBLEMS OF
FR2766708B1 (en) * 1997-07-30 2000-05-05 Galenix Dev COMPOSITION CONTAINING HYDROXYPROPYLCELLULOSE, HYDROXYPROPYLMETHYLCELLULOSE AND / OR ETHYLCELLULLOSE AS DISINTEGRANTS, AND PROCESS FOR OBTAINING SAME
CA2307370C (en) 1997-10-06 2004-02-10 Adalbert-Raps-Stiftung Method for producing a powder from a liquid substance or mixture of substances
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
HUP0103543A2 (en) * 1998-10-02 2002-01-28 3M Innovative Properties Company Mucosal originated drug delivery systems and animal applications
AU2367900A (en) * 1998-12-18 2000-07-03 Bayer Corporation Chewable drug delivery system
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
US6231957B1 (en) * 1999-05-06 2001-05-15 Horst G. Zerbe Rapidly disintegrating flavor wafer for flavor enrichment
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
DE19954245A1 (en) * 1999-11-11 2001-07-19 Lohmann Therapie Syst Lts Multi-layer film-like preparation made of hydrophilic polymers for the rapid release of active ingredients
DE60024491T2 (en) 1999-12-01 2006-08-10 Natco Pharma Ltd., Banjara Hills FAST-ACTIVE, FREEZER-DRY, ORAL, PHARMACEUTICAL FORMULATION FOR TREATMENT OF MIGRAINE
EP1120109A3 (en) * 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
KR100393478B1 (en) * 2000-03-29 2003-08-06 주식회사종근당 Self-emulsifying matrix type transdermal preparation
DE10032456A1 (en) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Rapidly disintegrating dosage form for the release of active substances in the mouth or in the body cavities

Similar Documents

Publication Publication Date Title
AU2002250904A1 (en) Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
HK1060055A1 (en) Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
AU2002347575A1 (en) Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
AU2001226029A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
IL162293A0 (en) Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
EE200400028A (en) Pharmaceutical preparation, method of its preparation and its use in medicine
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
HK1050673A1 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms
EP1583545A4 (en) Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy
AU2002317063A (en) Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
AU2002317063A1 (en) Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
IL160886A0 (en) Nicotine containing pharmaceutical formulations and use thereof
GB0113725D0 (en) Nasal delivery of pharmaceutical compositions including vaccines and biotechnological products
IL146276A0 (en) Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
PL365029A1 (en) Novel vaccine for prophylaxis and therapy in veterinary and human medicine
IL155855A0 (en) Pharmaceutical formulation of gepirone for oral administration